Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Related Citations for PubMed (Select 20427429)

1.

Comparing breast cancer risk assessment models.

Gail MH, Mai PL.

J Natl Cancer Inst. 2010 May 19;102(10):665-8. doi: 10.1093/jnci/djq141. Epub 2010 Apr 28. No abstract available.

2.

Assessing women at high risk of breast cancer: a review of risk assessment models.

Amir E, Freedman OC, Seruga B, Evans DG.

J Natl Cancer Inst. 2010 May 19;102(10):680-91. doi: 10.1093/jnci/djq088. Epub 2010 Apr 28. Review.

3.

The case for individualized screening recommendations for breast cancer.

Bradbury A, Olopade OI.

J Clin Oncol. 2006 Jul 20;24(21):3328-30. Epub 2006 Jun 26. No abstract available.

4.

Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.

Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D.

Genet Epidemiol. 2001 Jul;21(1):1-18.

PMID:
11443730
5.

Breast cancer in 2007: incidence, risk assessment, and risk reduction strategies.

Lester J.

Clin J Oncol Nurs. 2007 Oct;11(5):619-22. Review.

6.

Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.

Andrieu N, Easton DF, Chang-Claude J, Rookus MA, Brohet R, Cardis E, Antoniou AC, Wagner T, Simard J, Evans G, Peock S, Fricker JP, Nogues C, Van't Veer L, Van Leeuwen FE, Goldgar DE.

J Clin Oncol. 2006 Jul 20;24(21):3361-6. Epub 2006 Jun 26.

7.

Recent developments in the ability to predict and modify breast cancer risk.

Prado A, Andrades P, Parada F.

J Plast Reconstr Aesthet Surg. 2010 Oct;63(10):1581-7. doi: 10.1016/j.bjps.2009.06.034. Epub 2009 Aug 8. Review.

PMID:
19666246
9.

Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers.

Berrington de Gonzalez A, Berg CD, Visvanathan K, Robson M.

J Natl Cancer Inst. 2009 Feb 4;101(3):205-9. doi: 10.1093/jnci/djn440. Epub 2009 Jan 27.

10.

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.

Berry DA, Iversen ES Jr, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G.

J Clin Oncol. 2002 Jun 1;20(11):2701-12.

PMID:
12039933
11.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901
12.

Testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: a decision analysis.

Tengs TO, Winer EP, Paddock S, Aguilar-Chavez O, Berry DA.

Med Decis Making. 1998 Oct-Dec;18(4):365-75.

PMID:
10372578
13.

[Clinical and molecular diagnosis of inherited breast-ovarian cancer].

Chompret A.

J Gynecol Obstet Biol Reprod (Paris). 2003 Apr;32(2):101-19. Review. French.

14.

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.

Antoniou AC, Durocher F, Smith P, Simard J, Easton DF; INHERIT BRCAs program members.

Breast Cancer Res. 2006;8(1):R3. Epub 2005 Dec 12.

15.

Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature.

Calderon-Margalit R, Paltiel O.

Int J Cancer. 2004 Nov 10;112(3):357-64. Review.

PMID:
15382059
16.

Application of breast cancer risk prediction models in clinical practice.

Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL.

J Clin Oncol. 2003 Feb 15;21(4):593-601. Review.

PMID:
12586794
17.

BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling.

Palmieri G, Palomba G, Cossu A, Pisano M, Dedola MF, Sarobba MG, Farris A, Olmeo N, Contu A, Pasca A, Satta MP, Persico I, Carboni AA, Cossu-Rocca P, Contini M, Mangion J, Stratton MR, Tanda F.

Ann Oncol. 2002 Dec;13(12):1899-907.

18.

Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study.

de Sanjosé S, Léoné M, Bérez V, Izquierdo A, Font R, Brunet JM, Louat T, Vilardell L, Borras J, Viladiu P, Bosch FX, Lenoir GM, Sinilnikova OM.

Int J Cancer. 2003 Sep 10;106(4):588-93.

PMID:
12845657
19.

Breast cancer risk assessment and genetic testing: complexities, conundrums, and community.

Peshkin BN.

Breast Dis. 2006-2007;27:1-3. No abstract available.

PMID:
17917137
20.

Prevention and genetic testing for breast cancer: variations in medical decisions.

Bouchard L, Blancquaert I, Eisinger F, Foulkes WD, Evans G, Sobol H, Julian-Reynier C.

Soc Sci Med. 2004 Mar;58(6):1085-96.

PMID:
14723904
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk